Wolfram Samlowski, MD, FACP, earned his bachelor’s and medical degree from the Ohio State University in Columbus, Ohio. He completed his internal medicine residency at Wayne State University in Detroit, and his hematology/oncology fellowship at the University of Utah in Salt Lake City.
Dr. Wolfram Samlowski is a medical oncologist at Comprehensive Cancer Centers of Nevada (CCCN). He serves on the Developmental Therapeutics and Genitourinary Committees for US Oncology Research as well as a Clinical Professor of Medicine at University of Nevada School of Medicine. Dr. Samlowski has an expert in treating patients with melanoma and skin cancer, kidney cancer, sarcoma and serves as principle investigator on several clinical research studies available at CCCN.
Dr. Samlowski has contributed to and authored over 250 publications, peer reviews and abstracts. He is a member of several professional associations including the American Federation of Clinical Research, American Society for Clinical Oncology, American Association for Cancer Research, Society for Pigment Cell and Melanoma Research. He is also a Fellow of the American College of Physicians.
Prior to joining CCCN, Dr. Samlowski was Professor of Oncology and Adjunct Professor of Dermatology and Pathology at the Huntsman Cancer institute of the University of Utah. Dr. Samlowski also served as director of Translational Research, Multidisciplinary Melanoma program at the Huntsman Cancer Institute, where he worked from 1984 to 2007. In 2007, he joined the Nevada Cancer Institute as Chief of Melanoma, Renal Cancer and Immunotherapy, and was appointed Professor of Oncology. He also serves as Clinical Professor of Medicine at the University of Nevada School of Medicine.
Over the years, Dr. Samlowski has received numerous awards and honors. He has been named a “Top Doctor” by Vegas Seven and Las Vegas Life, “Best Doctor” by Desert Companion, and “America’s Top Doctors” and “America’s Top Oncologists” by Castle Connolly and US News and World Report. He was also named a “Healthcare Headliner” by Vegas, Inc. and “Medical Marvel” by Nevada Business Magazine.
Dr. Samlowski and his wife Suzanne have three grown children. His hobbies include skiing, coaching soccer, and traveling.
MEMBERSHIPS IN PROFESSIONAL ASSOCIATIONS
American College of Physicians, Fellow
American Federation of Clinical Research
American Society for Clinical Oncology
American Association for Cancer Research
Society for Pigment Cell and Melanoma Research
Clark County Medical Society
Las Vegas Urology Society
Hersh EM, O’Day SJ, Gonzales R, Ribas A, Samlowski WE, Gordon MS, Shechter D, Clawson A, Hawkins MJ. “A phase II trial of nab-paclitaxel in previously treated and chemotherapy naïve patients with metastatic malignant melanoma.” Cancer. 28;116:155-163, 2010. Read more.
Samlowski WE, Moon J, Tuthill RJ, Heinrich MC, Balzer-Haas NS, Merl SA, DeConti RC , Thompson JA, Witter MT, Flaherty LE, Sondak VK. “A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin): A Southwest Oncology Group phase II Study (S0331).” Am J Clin Oncol 33:495-499, 2010. Read more.
Samlowski EE, Dechet C, Weissman A, Samlowski WE. “Large cell non-Hodgkin’s lymphoma masquerading as renal carcinoma with IVC thrombosis: A case report.” Journal of Med Case Repts 5:245, 2011. Read more.
Eroglu Z, Kong M, Jakowatz JG, Akerly W, Samlowski W, Fruehauf JP. “Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma.” Cancer Chemother Pharmacol 68:1081-1087, 2011. Read more.
Gonsalves-Shapiro D, Samlowski WE. “Management of melanoma brain metastases in the era of targeted therapy.” In: Melanoma: From Research to Treatment, Ascierto, PA, Kirkwood, JA, Marincola F, Palmieri G., eds, Hinawi, New York, J Skin Cancer. 2011;2011:845863. Epub 2011 Dec 15. Read more.
Vogelzang NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE, Janne PA, Ko AH, Masters GA, Odenike O, Patel JD, Roth BJ, Samlowski WE, Seidman AD, Tap WD, Temel JS, Von Roenn JH, Kris MG. “Clinical cancer advances 2011: Annual report on progress against cancer from the American Society of Clinical Oncology.” J Clin Oncol. 30:88-109, 2012. Read more.
You can find more information about Dr. Samlowski on Wikipedia.